Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the efficacy and safety of radium-223 dichloride in subjects with HER2 negative, hormone receptor positive breast cancer with bone metastases treated with hormonal treatment background therapy.
Critère d'inclusion
- HER2 negative hormone receptor positive metastatic breast cancer with bone metastases treated with standard of care hormonal treatment